Technical Analysis for INSY - Insys Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 9.46 2.05% 0.19
INSY closed up 2.05 percent on Wednesday, August 16, 2017, on 84 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical INSY trend table...

Date Alert Name Type % Chg
Aug 16 NR7 Range Contraction 0.00%
Aug 16 Narrow Range Bar Range Contraction 0.00%
Aug 16 1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Aug 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Aug 14 Slingshot Bearish Bearish Swing Setup 2.27%

Older signals for INSY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
Is INSY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 18.42
52 Week Low 8.7
Average Volume 568,260
200-Day Moving Average 11.2442
50-Day Moving Average 11.6786
20-Day Moving Average 10.562
10-Day Moving Average 9.432
Average True Range 0.5215
ADX 36.16
+DI 10.81
-DI: 31.46
Chandelier Exit (Long, 3 ATRs) 11.2855
Chandelier Exit (Short, 3 ATRs) 10.3845
Upper Bollinger Band 12.9648
Lower Bollinger Band 8.1592
Percent B (%b) 0.27
Bandwidth 0.45499
MACD Line -0.8465
MACD Signal Line -0.7521
MACD Histogram -0.0944